NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

Harmonic Inc. (NASDAQ:HLIT – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat.com reports. Two equities research ...

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic ...

Harmonic Inc (HLIT) reports impressive revenue growth and profitability, while navigating industry transitions and market ...

Third Harmonic Bio, Inc. (THRD) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Harmonic Inc. (NASDAQ:HLIT – Get Free Report) reached a new 52-week low during trading on Tuesday after Rosenblatt Securities ...

Third Harmonic Bio, Inc.’s THRD share price has dipped by 30.11%, which has investors questioning if this is right time to buy.

It's been a sad week for Harmonic Inc. ( NASDAQ:HLIT ), who've watched their investment drop 17% to US$9.51 in the ...

Third Harmonic Bio, Inc. (THRD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LOS ANGELES, Feb. 13, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Harmonic Inc. ("Harmonic" or "the Company") (NASDAQ: HLIT ...